Will Walt Disney’s (NYSE: DIS ) Marvel Studios nab a big win at the Captain America: The Winter Soldier box office? The newest Marvel movie opened in 3,938 U.S. cinemas this weekend. In this episode of 1-Up On Wall Street, The Motley Fool’s web show in which we talk about the big-money names behind your favorite movies, toys, video games, comics, and more, host Ellen Bowman asks Fool analysts Nathan Alderman and Tim Beyers if the new Captain America epic exhibits the blockbuster bonafides we’ve come to expect from a Marvel movie.
Chris Evans as Captain America and Scarlett Johansson as Black Widow in Captain America: The Winter Soldier. Credit: Marvel Entertainment.
Nathan predicts a strong opening, citing excellent reviews for the movie and a $75.2 million initial haul in its overseas debut, an admirable performance when viewed in context. Captain America: The Winter Soldier opened in 32 territories outside the U.S. a week ago.
Best Consumer Service Stocks To Own Right Now: Kadant Inc (KAI)
Kadant Inc., incorporated in November 1991, is a supplier of equipment used in the global papermaking and paper recycling industries and a manufacturer of granules made from papermaking byproducts. Through its Papermaking Systems segment, the Company develops, manufactures and markets a range of equipment and products for the global papermaking, paper recycling, and process industries. Through its Fiber-based Products business, the Company manufacture and sell granules derived from pulp fiber for use as carriers for agricultural, home lawn and garden, and professional lawn, turf and ornamental applications, as well as for oil and grease absorption. Its Papermaking Systems segment consists of product lines, such as stock-preparation, fluid-handling, doctoring and water-management. On May 27, 2011, its subsidiary, Kadant Johnson Europe B.V., acquired all the interests in m-clean papertech holding AB. In April 2013, it completed the acquisition of Companhia Brasileira de Tecn ologia Industrial (CBTI).
The Company’s customer base includes major global paper manufacturers and with its equipment found in most of pulp and paper mills. The Company manufactures its products in nine countries in Europe, North and South America and Asia. It develop, manufacture and market complete custom-engineered systems and equipment, as well as standard individual components, for pulping, de-inking, screening, cleaning, and refining recycled and virgin fibers for preparation for entry into the paper machine. Its principal stock-preparation products include recycling and approach flow systems and Virgin pulping process equipment.
The Company develop, manufacture and market rotary joints, precision unions, steam and condensate systems, components, and controls used primarily in the dryer section of the papermaking process and during the production of corrugated boxboard, metals, plastics, rubber, textiles, chemicals and food. Its principal f luid-handling systems include rotary joints, siphons, turbul! ator bars, and engineered steam and condensate systems. Its mechanical devices, used with rotating shafts, allow the transfer of pressurized fluid from a stationary source into and out of rotating machinery for heating, cooling, or the transfer of fluid power. Its devices, installed primarily inside the rotating cylinders of paper machines, are used to remove condensate from the drying cylinders through rotary joints located on either end of the cylinder. Its steel or stainless steel axial bars, installed on the inside of cylinders, are used to induce turbulence in the condensate layer to improve the uniformity and rate of heat transfer through the cylinders. Its steam systems control the flow of steam from the boiler to the paper drying cylinders, collect condensed steam, and return it to the boiler to improve energy efficiency during the paper drying process.
The Company develop, manufacture and market a range of doctoring systems and related consumables that continuously clean rolls to keep paper machines running efficiently; doctor blades made of a variety of materials to perform functions, including cleaning, creping, web removal, flaking, and the application of coatings, and profiling systems that control moisture, Web curl, and gloss during paper converting. Its principal doctoring products include doctor systems and holders, profiling systems and doctor blades. Its doctor systems clean papermaking rolls to maintain the operation of paper machines and other equipment by placing a blade against the roll at a constant and uniform pressure. A doctor system consists of the structure supporting the blade and the blade holder. It offers profiling systems that control moisture, Web curl, and gloss during paper converting. It manufacture doctor and scraper blades made of a variety of materials, including metal, bi-metal, or synthetic materials that perform a variety of functions, including cleaning, creping, Web removal, flaking and the application of coatings.
The Company devel! ops, manu! facture and markets water-management systems and equipment used to continuously clean paper machine fabrics and rolls, drain water from pulp mixtures, form the sheet or Web, and filter the process water for reuse. Its principal water-management systems include shower and fabric-conditioning systems, formation systems, and water-filtration systems. Its shower and fabric-conditioning systems assist in the removal of contaminants that collect on paper machine fabrics used to convey the paper Web through the forming, pressing and drying sections of the paper machine. A typical paper machine has between 3 and 12 fabrics. It supplies structures that drain, purify, and recycle process water from the pulp mixture during paper sheet and Web formation. It offer a variety of filtration systems and strainers that remove contaminants from process water before reuse and recover reusable fiber for recycling back into the pulp mixture.
The Company competes with Voith Paper GmbH , Metso Corporation, Maschinenfabrik Andritz AG, Deublin Company, Barco Company, Christian Maier GmbH & Co. KG, Duff-Norton Company, Joh. Clouth GmbH & Co. KG, Bonetti, S.p.A., Metso Corporation and IBS-Paper Performance Group.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Kadant (NYSE: KAI ) , whose recent revenue and earnings are plotted below.
Best Consumer Service Stocks To Own Right Now: CEL-SCI Corp (CVM)
CEL-SCI Corporation (CEL-SCI), incorporated on March 22, 1983, is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
CEL-SCI’s Multikine, is being developed for the treatment of cancer. It is a cancer immunotherapy drugs called Combination Immunotherapy because it combines active and passive immunity in one product. It is the only cancer immunotherapy that both kills cancer cells and activates the general immune system to destroy the cancer. Multikine target the tumor micro-metastases for treatment failure. Multikine is also applicable in many other solid tumors.
New Manufacturing Facility
CEL-SCI’s facility manufactures Multikine for CEL-SCI’s Phase III clinical trial. CEL-SCI offers the use of the facility as a service to pharmaceutical companies and others, particularly those that need to fill and finish their drugs in a cold environment. Fill and finish is the process of filling injectable drugs in a sterile manner.
CEL-SCI’s patented T-cell Modulation Process uses heteroconjugates to direct the body to choose a specific immune response. The heteroconjugate technology, referred to as LEAPS, is intended to stimulate the human immune system to fight bacterial, viral and parasitic infections, as well as autoimmune, allergies, transplantation rejection and cancer. Administered like vaccines, LEAPS combines T-cell binding ligands with small, disease associated and peptide antigens.
Using the LEAPS technology, CEL-SCI has created a peptide treatment for H1N1 (swine flu) hospitalized patients. This LEAPS flu treatment is designe d to focus on the conserved, non-changing epitopes of the di! fferent strains of Type A Influenza viruses, including swine, avian or bird, and Spanish Influenza. CEL-SCI’s LEAPS flu treatment contains epitopes.
- [By James E. Brumley]
Little TNI Biotech Inc. (OTCMKTS:TNIB) just gave bigger immunology players like Amgen, Inc. (NASDAQ:AMGN) or CEL-SCI Corporation (NYSEMKT:CVM) a new reason to worry. Though CVM and AMGN aren’t exactly sweating bullets yet, TNIB has taken not a big step forward in terms biotechnological progress, but rather, has widened its net with a lateral expansion.
- [By Bryan Murphy]
It may not have blazed a trail into the young, immunology segment of the biotech industry the way Dendreon Corporation (NASDAQ:DNDN) did back in 2010 with the debut of Provenge. It may not have the same immunology pipeline (and company size) that ImmunoGen, Inc. (NASDAQ:IMGN) boasts. One thing is pretty certain about cancer-immunotherapy developer CEL-SCI Corporation (NYSEMKT:CVM) right now, however – its stock may be poised to dole out a much bigger foreseeable-future reward than DNDN or IMGN are.
- [By Bryan Murphy]
Look out AbbVie Inc. (NYSE:ABBV), and Gilead Sciences, Inc. (NASDAQ:GILD), you may want to look over your shoulder as well. There’s a new immunology player coming to town, and its name is CEL-SCI Corporation (NYSEMKT:CVM). Yes, AbbVie may be the name behind blockbuster drug Humira – with nearly $10 billion in sales in 2012 – while Gilead Sciences is saving HIV patients’ lives with immunological therapies Stribild and Complera. But, small cap company CEL-SCI may be closer to launching its own immunology drug sooner than most investors realize.
- [By Bryan Murphy]
Names like Amgen, Inc. (NASDAQ:AMGN) and CEL-SCI Corporation (NYSEMKT:CVM) may have pioneered and even mainstreamed the idea of cancer immunology, but the nature of the branch of biotechnology means any company could send CEL-SCI or Amgen back-pedaling. See, it’s not about size or deep pockets in the world of biotech anymore. It’s about know-how and an idea, which can just as easily be discovered and developed by a small company as they can be a large company. That’s why AMGN and CVM at least need to keep a close eye on budding immunology competitor TNI Biotech Inc. (OTCMKTS:TNIB).
Best Consumer Service Stocks To Own Right Now: Intellipharmaceutics International Inc.(IPCI)
Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel or generic controlled and targeted release oral solid dosage drugs. The company?s patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of various existing and new pharmaceuticals. It has a pipeline of products in various stages of development in therapeutic areas, including neurology, cardiovascular, and gastrointestinal tract, pain, and infection. The company?s lead generic product under development includes generic Focalin XR (dexmethylphenidate hydrochloride), an extended-release capsule for the treatment of attention deficit hyperactivity disorder. Intellipharmaceutics has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. The company also has five generic products filed with the FDA, including a gene r ic of Effexor XR (venlafaxine hydrochloride), an extended-release capsule for depression; Protonix (pantoprazole sodium), a delayed-release tablet for conditions associated with gastroesophageal disease; Glucophage XR (metformin hydrochloride), an extended-release tablet for managing type 2 diabetes; Seroquel XR (quetiapine fumarate), an extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; and Lamictal XR (lamotrigine), an extended-release tablet for the treatment of anti-convulsant for epilepsy. Its lead non-generic product under development is Rexista (oxycodone), an abuse- and alcohol-deterrent controlled-release oral oxycodone hydrochloride formulation for the relief of pain. The company also has a under late stage development product, such as Coreg CR (carvedilol phosphate), an extended-release capsule for hypertension and heart conditions. IntelliPharmaCeutics International Inc. was founded in 1998 and is based i n Toronto, Canada.
- [By Roberto Pedone]
A pharmaceutical player that’s starting to trend within range of triggering a big breakout trade is IntelliPharmaCeutics (IPCI), which specializing in the research, development and manufacture of generic controlled-release and targeted-release oral solid dosage drugs. This stock has been on fire over the last three months, with shares up a whopping 99%.
If you take a look at the chart for IntelliPharmaCeutics, you’ll notice that this stock has been uptrending a bit over the last few weeks, with shares moving higher from its low f $3.12 to its recent high of $4.37 a share. During that uptrend, shares of IPCI have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of IPCI within range of triggering a big breakout trade above some key overhead resistance levels.
Traders should now look for long-biased trades in IPCI if it manages to break out some near-term overhead resistance levels at $4.37 to $4.62 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.31 million shares. If that breakout triggers soon, then IPCI will set up to re-test or possibly take out its 52-week high at $6.46 a share.
Traders can look to buy IPCI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.36 or at its 50-day moving average of $3.13 a share. One could also buy IPCI off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Consumer Service Stocks To Own Right Now: Nordson Corporation(NDSN)
Nordson Corporation manufactures equipment used for precision dispensing, testing and inspection, and surface preparation and curing. Its Adhesive Dispensing Systems segment manufactures equipment for applying adhesives, lotions, and liquids to disposable products; automated adhesive dispensing systems for the food and beverage, and packaged goods industries; hot melt and cold glue adhesive dispensing systems for the paper and paperboard converting industries; adhesive and sealant dispensing systems for bonding or sealing plastic, metal, and wood products; and laminating and coating systems to manufacture continuous-roll goods in the nonwovens, textile, paper, and flexible-packaging industries. The company?s Advanced Technology Systems segment comprises automated gas plasma treatment systems used to clean and condition surfaces for the semiconductor, medical, and printed circuit board industries; controlled manual and automated systems for applying materials in customer pr ocesses requiring precision and material conservation; ultraviolet equipment used in curing and drying operations for specialty coatings, semiconductor materials, and paints; and bond testing and automated optical and x-ray inspection systems used in the semiconductor and printed circuit board industries. Its Industrial Coating Systems segment provides automated and manual dispensing systems used for applying coatings, paint, finishes, sealants, and other materials. Nordson Corporation markets its products in the United States and internationally through a direct sales force, as well as through qualified distributors and sales representatives. It serves various markets, including the appliance, automotive, bookbinding, container, converting, electronics, food and beverage, furniture, life sciences and medical, metal finishing, non woven, packaging, and semiconductor industries. The company was founded in 1935 and is headquartered in Westlake, Ohio.
- [By Lauren Pollock]
Nordson Corp.’s(NDSN) fiscal fourth-quarter earnings fell 12% on weaker demand, though the maker of dispensing equipment noted improvement in recent order trends.
- [By Travis Hoium]
What: Shares of industrial product manufacturer Nordson (NASDAQ: NDSN ) dropped as much as 10% today after the company reported fiscal second-quarter earnings.
Best Consumer Service Stocks To Own Right Now: Bollore SA (BOL)
Bollore SA is a France-based holding company which operates in 110 countries. The Company is active in several divisions: Bollore Africa Logistics, including freight forwarding, stevedoring, shipping lines and railways; Bollore Logistics with a presence in five continents; Bollore Energie which supplies domestic fuel and petroleum products; IER which designs, manufacture and markets terminals for controlling and reading tickets; Plastic Films for condensers, capacitors and packaging; Batteries and Supercapacitors, Electric Vehicles; Autolib’ which offers a network of electric car rental; Communication and Media, which launched Digital Terrestial Television (DTT); Plantations because the Company owns oil palm and rubber plantations, through the Socfin Group and Financial Assets. As of September 27, 2012, the Company acquired minority stake in Vivendi SA and sold Direct 8 and Direct Star to Canal Plus SA. In January 2014, it acquired the outstanding 51% stake of LCN. Advisors’ Opinion:
- [By Sofia Horta e Costa]
Rio Tinto Group climbed 2.9 percent after saying it will cost $3 billion less than projected to increase iron ore output capacity. Boliden AB (BOL) added 3.1 percent as Morgan Stanley raised its rating on the stock. Thomas Cook Group Plc (TCG) rose 13 percent after the travel operator posted a 49 percent increase in full-year earnings. British tobacco companies slipped following a report that after a U.K. minister announced the review of cigarette packaging.
Best Consumer Service Stocks To Own Right Now: Hawkins Inc. (HWKN)
Hawkins, Inc. distributes bulk chemicals, as well as blends, manufactures, and distributes specialty chemicals. The company operates through two segments, Industrial and Water Treatment. The Industrial segment provides industrial chemicals, products, and services primarily to the agriculture, energy, electronics, food, chemical processing, pulp and paper, pharmaceutical, medical device, and plating industries. This segment primarily offers acids, alkalis, and industrial and food-grade salts; and receives, stores, and distributes various chemicals, including liquid caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. In addition, it manufactures sodium hypochlorite, agricultural products, and certain food-grade products comprising Cheese-Phos liquid phosphate, lactates, and other blended products; repackages water treatment and bulk industrial chemicals; and performs custom blending of certain chemicals, and contract and pr ivate label packaging for household chemicals. This segment primarily conducts its operations through distribution centers and terminal operations. The Water Treatment segment provides chemicals, equipment, and solutions for potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Hawkins, Inc. was founded in 1938 and is based in Minneapolis, Minnesota.
- [By Seth Jayson]
Hawkins (Nasdaq: HWKN ) reported earnings on May 29. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q4), Hawkins met expectations on revenues and beat expectations on earnings per share.
Best Consumer Service Stocks To Own Right Now: Pimco Corporate & Income Opportunity Fund (PTY)
PIMCO Corporate Opportunity Fund (the Fund) is a diversified closed-end management investment company. The Fund’s investment objective is to seek maximum total return through a combination of current income and capital appreciation in a diversified portfolio of United States dollar-denominated corporate debt obligations of varying maturities and other income producing securities. The Fund will normally focus on corporate debt obligations rated in the lowest investment-grade category (Baa or BBB) and in the highest non-investment-grade category (Ba or BB). Its portfolio includes corporate bonds and notes, the United States Government agency securities, sovereign debt obligations, municipal bonds, mortgage-backed securities, asset-backed securities and short-term investments.
The Fund invests in residual interest municipal bonds and residual interest tax exempt bonds (inverse floaters), whose interest rates bear an inverse relationship to the interest rate on another security or the value of an index. PIMCO Corporate Opportunity Fund may purchase and write (sell) put and call options. The Fund may sell options on the United States Treasury futures and other fixed-income instruments. PIMCO Corporate Opportunity Fund invests in various industries, including airlines, banking, energy, financial services, food and beverage, hotels/gaming, oil and gas, paper/paper products, telecommunications and utilities. The Fund’s investment manager is Allianz Global Investors Fund Management LLC, which is an indirect wholly owned subsidiary of Allianz Global Investors of America L.P. PIMCO Corporate Opportunity Fund’s sub-advisor is Pacific Investment Management Company LLC.
- [By Dan Caplinger]
Lesson 1: Income is king.
A look at the four funds trading at the highest premiums to net asset value reveals a common thread: They’re all focused on maximizing income. What’s interesting, though, is that they use different methods to reach the same ends. Among the three PIMCO funds, PIMCO High Income (NYSE: PHK ) looks largely to the high-yield bond market for its holdings, while PIMCO Corporate & Income Opportunities (NYSE: PTY ) has a somewhat lower distribution rate but has a sizable allocation to investment-grade debt. The fund with the highest premium, PIMCO Global StocksPLUS, uses futures contracts to add stock exposure to its portfolio of income-producing bonds. Finally, BlackRock Virginia Municipal Bond rounds out the top four with its tax-free bond portfolio.
Best Consumer Service Stocks To Own Right Now: O’Reilly Automotive Inc.(ORLY)
O?Reilly Automotive, Inc., together with its subsidiaries, engages in the retail of automotive aftermarket parts, tools, supplies, equipment, and accessories in the United States. The company?s stores provide new and remanufactured automotive hard parts, including alternators, starters, fuel pumps, water pumps, brake system components, batteries, belts, hoses, chassis parts, and engine parts; maintenance items comprising oil, antifreeze, fluids, filters, wiper blades, lighting, engine additives, and appearance products; and accessories, such as floor mats, seat covers, and truck accessories. Its stores also offer auto body paint and related materials, automotive tools, and professional service provider service equipment. The company?s stores sell its brand name and private label products for domestic and imported automobiles, vans, and trucks to do-it-yourself customers and professional service providers. As of March 31, 2011, it operated 3,613 stores. The company was foun ded in 1957 and is headquartered in Springfield, Missouri.
- [By James E. Brumley]
O’Reilly Automotive Inc. (NASDAQ:ORLY), AutoZone, Inc. (NYSE:AZO), The Pep Boys – Manny, Moe & Jack (NYSE:PBY), and Advance Auto Parts, Inc. (NYSE:AAP) may all technically be in the same business, but they’re hardly in the same proverbial boat. In fact, their performances – sales and earnings – are oddly disparate. Which among PBY, AZO, ORLY, and AAP are the winners and the losers, and perhaps more important, why? The question can at least partially be answered by a chart, and what the chart can’t tell us about each, the narrative can.
- [By Matt Thalman]
One of the larger players by market capitalization within the industry is O’Reilly Automotive (NASDAQ: ORLY ) , with a market capitalization of $15.75 billion after today’s stock price increase of 9.04%. That move higher came after the company reported a 23% increase in fourth-quarter diluted earnings per share, which hit $1.40 after sales rose 9% to hit $1.62 billion when compared to the same quarter a year ago. Furthermore, this increase to diluted earnings per share marked the 20th consecutive quarterly increase of 15% or more. The company also reported that year-end sales rose 8%, to $6.65 billion, and a 27% increase to diluted earnings per share, which came in at $6.03.
- [By John Kell]
O’Reilly Automotive Inc.’s(ORLY) fourth-quarter net grew 15%, as the auto-parts retailer reported higher same-store sales.
Plains All American Pipeline LP(PAA) said its fourth-quarter earnings fell 13%, hurt by weaker adjusted results at its supply-and-logistics business.
- [By Sue Chang and Ben Eisen]
O’Reilly Automotive Inc. (ORLY) shares advanced 9.2% after it reported fourth-quarter earnings of $1.40 a share, above the $1.33 forecast by analysts. Shares of automotive parts retailer AutoZone Inc. (AZO) rose 5.5%.